LBL-024 binds 4-1BB on T cells and PD-L1 on tumor cells, blocking PD-L1/PD-1 and providing 4-1BB costimulation to activate T cells. The activated T cells then kill PD-L1–positive tumor cells; 4-1BB–expressing cells themselves are not killed.